Greek Organisation of Football Prognostics SA Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Buy

54

GOFPY
Greek Organisation of Football Prognostics SA

Last Price:

$10.77

Seasonality Move:

7.35%

Sell

34

MNPR
Monopar Therapeutics, Inc.

Last Price:

$64.98

Seasonality Move:

25.93%

Buy

54

Greek Organisation of Football Prognostics SA (GOFPY) is a Buy

Is Greek Organisation of Football Prognostics SA a Buy, Sell or Hold?

The current Greek Organisation of Football Prognostics SA [GOFPY] share price is $10.54. The Score for GOFPY is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
GOFPY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

34

Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

The current Monopar Therapeutics, Inc. [MNPR] share price is $67.70. The Score for MNPR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GOFPY Stock Price Chart

What is Greek Organisation of Football Prognostics SA's stock price today?

The Greek Organisation of Football Prognostics SA share price today is $10.54

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GOFPY is experiencing selling pressure, which indicates risk of future bearish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

The Monopar Therapeutics, Inc. share price today is $67.70

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.

GOFPY Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.11	Buy
Relative Strength Index (14 RSI):	50.81	Buy
Chaikin Money Flow:	-19284	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(9.97 - 10.71)	Buy
Bollinger Bands (100):	(10.34 - 11.7)	Sell

MNPR Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-2.86	Sell
Relative Strength Index (14 RSI):	33.87	Sell
Chaikin Money Flow:	-124010	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(74.34 - 86.38)	Sell
Bollinger Bands (100):	(44.81 - 88.99)	Buy

GOFPY Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	10.76	Sell
20-day SMA:	10.43	Buy
50-day SMA:	10.48	Buy
200-day SMA:	10.89	Sell
8-day EMA:	10.68	Sell
20-day EMA:	10.54	Buy
50-day EMA:	10.6	Sell
200-day EMA:	10.57	Sell

MNPR Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	74.5	Sell
20-day SMA:	80.22	Sell
50-day SMA:	82.77	Sell
200-day SMA:	51.96	Buy
8-day EMA:	74.03	Sell
20-day EMA:	77.79	Sell
50-day EMA:	77.58	Sell
200-day EMA:	56.47	Buy

Greek Organisation of Football Prognostics SA Earnings Growth & GOFPY Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Greek Organisation of Football Prognostics SA Technical Analysis

	Dec 4	Dec 5	Dec 8	Dec 9	Dec 10	Dec 11	Dec 12	Dec 15	Dec 16	Dec 17
	Dec
	04	05	08	09	10	11	12	15	16	17
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

	Dec 4	Dec 5	Dec 8	Dec 9	Dec 10	Dec 11	Dec 12	Dec 15	Dec 16	Dec 17
	Dec
	04	05	08	09	10	11	12	15	16	17
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):